Global Health Limited

BSE:543654 Stock Report

Market Cap: ₹287.2b

Global Health Valuation

Is 543654 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543654 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
₹472.50
Fair Value
127.2% overvalued intrinsic discount
13
Number of Analysts

Below Fair Value: 543654 (₹1073.55) is trading above our estimate of fair value (₹472.5)

Significantly Below Fair Value: 543654 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543654?

Key metric: As 543654 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 543654. This is calculated by dividing 543654's market cap by their current earnings.
What is 543654's PE Ratio?
PE Ratio59x
Earnings₹4.88b
Market Cap₹287.17b

Price to Earnings Ratio vs Peers

How does 543654's PE Ratio compare to its peers?

The above table shows the PE ratio for 543654 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average73x
NH Narayana Hrudayalaya
34.2x13.4%₹270.2b
ASTERDM Aster DM Healthcare
111.1x37.0%₹256.5b
KIMS Krishna Institute of Medical Sciences
78.5x25.0%₹261.6b
RAINBOW Rainbow Children's Medicare
68.1x24.0%₹161.7b
543654 Global Health
59x20.1%₹287.2b

Price-To-Earnings vs Peers: 543654 is good value based on its Price-To-Earnings Ratio (59x) compared to the peer average (73x).

Price to Earnings Ratio vs Industry

How does 543654's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.2xn/aUS$13.26m
542918 Gian Life Care
5xn/aUS$2.32m
No more companies available in this PE range
543654 59.0xIndustry Avg. 44.9xNo. of Companies9PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 543654 is expensive based on its Price-To-Earnings Ratio (59x) compared to the Indian Healthcare industry average (44.9x).

Price to Earnings Ratio vs Fair Ratio

What is 543654's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543654 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio59x
Fair PE Ratio62.2x

Price-To-Earnings vs Fair Ratio: 543654 is good value based on its Price-To-Earnings Ratio (59x) compared to the estimated Fair Price-To-Earnings Ratio (62.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543654 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,073.55
₹1,184.69
+10.4%
13.3%₹1,440.00₹855.00n/a13
Jan ’26₹1,101.05
₹1,187.38
+7.8%
12.8%₹1,440.00₹855.00n/a13
Dec ’25₹1,075.25
₹1,184.25
+10.1%
13.3%₹1,440.00₹855.00n/a12
Nov ’25₹1,115.50
₹1,193.36
+7.0%
12.5%₹1,400.00₹895.00n/a11
Oct ’25₹1,001.05
₹1,207.18
+20.6%
12.5%₹1,400.00₹930.00n/a11
Sep ’25₹1,133.85
₹1,233.90
+8.8%
10.4%₹1,390.00₹980.00n/a10
Aug ’25₹1,223.90
₹1,393.00
+13.8%
6.3%₹1,490.00₹1,245.00n/a9
Jul ’25₹1,271.20
₹1,376.10
+8.3%
10.3%₹1,620.00₹1,089.00n/a10
Jun ’25₹1,192.90
₹1,376.10
+15.4%
10.3%₹1,620.00₹1,089.00n/a10
May ’25₹1,444.90
₹1,352.70
-6.4%
9.8%₹1,530.00₹1,089.00n/a10
Apr ’25₹1,329.60
₹1,336.33
+0.5%
9.6%₹1,470.00₹1,089.00n/a9
Mar ’25₹1,298.60
₹1,336.33
+2.9%
9.6%₹1,470.00₹1,089.00n/a9
Feb ’25₹1,196.60
₹992.00
-17.1%
9.4%₹1,120.00₹875.00n/a9
Jan ’25₹951.45
₹958.63
+0.8%
6.9%₹1,050.00₹875.00₹1,101.058
Dec ’24₹971.10
₹958.63
-1.3%
6.9%₹1,050.00₹875.00₹1,075.258
Nov ’24₹800.90
₹790.00
-1.4%
5.7%₹859.00₹735.00₹1,115.508
Oct ’24₹715.50
₹780.14
+9.0%
5.0%₹840.00₹735.00₹1,001.057
Sep ’24₹707.25
₹754.33
+6.7%
3.1%₹780.00₹720.00₹1,133.856
Aug ’24₹678.85
₹687.80
+1.3%
7.9%₹780.00₹620.00₹1,223.905
Jul ’24₹659.65
₹667.50
+1.2%
4.8%₹710.00₹620.00₹1,271.204
Jun ’24₹586.90
₹653.33
+11.3%
3.7%₹675.00₹620.00₹1,192.903
May ’24₹514.75
₹585.00
+13.6%
5.7%₹630.00₹550.00₹1,444.903
Apr ’24₹526.15
₹602.50
+14.5%
4.6%₹630.00₹575.00₹1,329.602
Mar ’24₹509.85
₹602.50
+18.2%
4.6%₹630.00₹575.00₹1,298.602
Analyst Price Target
Consensus Narrative from 13 Analysts
₹1.19k
Fair Value
9.5% undervalued intrinsic discount
13
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 11:36
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Global Health Limited is covered by 20 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited
null nullAsian Markets Securities Private Limited